Guerbet reinforces its expertise with the launch of Contrast&Care®, a contrast media injection management solution for radio...
November 23 2017 - 2:02AM
Contrast&Care® has just obtained CE mark
Contrast&Care will be presented at the
RSNA
Villepinte (France), November 23, 2017
(8:00 CET) - Guerbet (FR0000032526 GBT), the global specialist
in contrast products and solutions for medical imaging, today
announces the launch of Contrast&Care®, a new contrast media
injection management solution for radiology centers.
The launch of the solution is part of the
strategy of Guerbet to develop a portfolio of digital solutions to
optimize the care and management of patients by healthcare
professionals.
Contrast&Care® is an integrated IT solution
that groups together all the information related to exams requiring
the injection of contrast media (contrast media, injection
protocol, patient data, etc.) and that interfaces with information
systems used in radiology such as the Radiology Information System
(RIS) or the Picture Archiving and Communication System (PACS).
The information generated by compatible
injectors is transmitted automatically to Contrast&Care® at the
end of each exam. This enables users to view the history of each
patient, the exams with injection that have been performed and the
doses of contrast media administered. Contrast&Care also offers
the option of reviewing protocols, creating protocol libraries, and
viewing statistics and trends relative to injection activity and
the use of contrast media.
"Contrast&Care®was conceived by Guerbet to
improve traceability and help healthcare professionals make
decisions on a daily basis. With these new digital solutions,
Contrast&Care® today, and Dose&Care® launched at the
beginning of 2017, Guerbet has completed its integrated offers so
radiology centers may make the most of the technological advances
available today.", comments Levi Cheng, Director of the Imaging
Solutions & Services Business Unit.
The commercial launch of Contrast&Care® will
start at the beginning of 2018.
The Guerbet teams will present
Contrast&Care® at all the upcoming international radiological
congresses where specialists will perform interactive
demonstrations (at the RSNA booth #1341 Hall A, the ECR,
etc...).
About Contrast&Care®
Contrast&Care® is a class I /CE medical
device designed to be used by healthcare professionals only. It is
a contrast product injection management solution that enables
imaging centers to collect, archive, examine and share injection
data, including data on contrast products, adverse events, injector
activity, information on estimated glomerular filtration rate
(eGFR) and other risk factors before an exam.
For more information, please refer to the
information leaflet and instructions for use. Contrast&Care® is
manufactured by Medex, a subsidiary of the Guerbet Group
(Saint-Priest France).
About Dose&Care®
Dose&Care® is a solution for managing and
analyzing the dose of X Rays patients receive during medical
imaging exams. It is intended for use by medical and diagnostic
imaging professionals and by the personnel in charge of safety and
X Ray administration in imaging centers.
For more information, please refer to the
information leaflet and instructions for use.
Dose&Care® is a class I /CE medical
device manufactured by MPTronic (Paris, France) and distributed by
Guerbet, (Roissy CdG cedex, France).
About Guerbet
Guerbet is a pioneer in the contrast agent field
with over 90 years' experience and is one of the leaders in medical
imaging worldwide. The Group offers a full range of pharmaceutical
products, medical devices and services for X-ray (RX) and Magnetic
Resonance Imaging (MRI) scanners and Interventional Radiology
Theranostics (IRT) to improve the diagnosis and treatment of
patients. With 7% of its revenue dedicated to R&D and more than
200 employees working in three centers in France and the United
States, Guerbet invests heavily in research and innovation. Guerbet
(GBT) is listed on Euronext Paris (Segment B - Mid Caps) and
generated €776 million in revenue in 2016. For more information
about Guerbet, visit www.guerbet.com
Media Relations Contacts
Guerbet Global Alize RP Caroline Carmagnol et Wendy
Rigal +33 (0)1 44 54 36 66 /
+33 (0)6 48 82 18 94
guerbet@alizerp.com |
|
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/d9f0296c-cdee-4902-8759-c76b769ff18e
Guerbet (EU:GBT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Guerbet (EU:GBT)
Historical Stock Chart
From Jul 2023 to Jul 2024